Lung Neuroendocrine Neoplasm — Trials

Lung Neuroendocrine Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,149 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03334487	Study Evaluating the Safety of Rovalpituzumab Tesirine for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Small Cell Lung Cancer	withdrawn	Phase 3	0	AbbVieINDUSTRY	7	Dec 26, 2018	clinicaltrials
NCT01563601	Efficacy and Safety of Obatoclax Mesylate in Combination With Carboplatin and Etoposide Compared With Carboplatin and Etoposide Alone in Chemotherapy-Naive Patients With Extensive-Stage Small Cell Lung Cancer	withdrawn	Phase 3	0	CephalonINDUSTRY	0	Aug 15, 2012